NR 546 FINAL EXAM REVIEW: KEY
CONCEPTS AND Q&A LATEST
2026/2027 ACTUAL EXAM QUESTIONS
WITH CORRECT ANSWERS 100%
VERIFIED GRADED A+
1. MechanismmofmSSRIsm-
mCORRECTmANSWERmInhibitmserotoninmreuptake,mincreasingmsynapticmserotonin.
2. SSRImwithmhighestmriskmofmdiscontinuationmsyndromem-mCORRECTmANSWERmParoxetine.
3. Neurotransmittersminmmonoaminemhypothesismofmdepressionm-
mCORRECTmANSWERmSerotonin,mnorepinephrine,mandmdopamine.
4. SafestmSSRIminmpolypharmacymandmelderlym-mCORRECTmANSWERmEscitalopram.
5. Classmofmantidepressantmrequiringmdietarymtyraminemrestrictionm-
mCORRECTmANSWERmMAOIs.
6. Hallmarkmsymptommofmserotoninmsyndromem-
mCORRECTmANSWERmHyperreflexiamandmclonus.
7. Opioidmwithdrawalmmedicationmwithmceilingmeffectm-mCORRECTmANSWERmBuprenorphine.
8. Medicationmcontraindicatedminmeatingmdisordersm-mCORRECTmANSWERmBupropion.
9. Antidepressantmassociatedmwithmpriapismm-mCORRECTmANSWERmTrazodone.
,10. MostmactivatingmSSRImthatmmaymworsenmanxietym-mCORRECTmANSWERmFluoxetine.
11. Medicationmclassmbestmavoidedminmelderlym-mCORRECTmANSWERmBenzodiazepines.
12. Mechanismmofmactionmofmmemantinem-mCORRECTmANSWERmNMDAmreceptormantagonist.
13. Dementiammedicationmderivedmfrommdaffodilsm-mCORRECTmANSWERmGalantamine.
14. Brainmregionmessentialmformmemorymformationm-mCORRECTmANSWERmHippocampus.
15. Uniquemriskmofmlamotriginemtherapym-mCORRECTmANSWERmStevens-Johnsonmsyndrome.
16. First-linemmedicationmformrestlessmlegsmsyndromem-mCORRECTmANSWERmRopinirole.
17. MOAmofmatomoxetinemformADHDm-
mCORRECTmANSWERmNorepinephrinemreuptakeminhibition.
18. PreferredmADHDmmedicationmformpatientsmwithmsubstancemusemhistorym-
mCORRECTmANSWERmAtomoxetine.
19. Majormsidemeffectmofmdonepezilm-mCORRECTmANSWERmGImdistressm(nausea,mdiarrhea).
20. BiomarkermelevatedminmAlzheimer'smdiseasemtanglesm-mCORRECTmANSWERmTaumprotein.
21. Keymcounselingmpointmformcholinesteraseminhibitorsm-
mCORRECTmANSWERmStartmlowmandmincreasemslowlymtomminimizemGImupset.
, 22. Preferredmfirst-linemtreatmentmformagitationminmdementiam-
mCORRECTmANSWERmSSRIs/SNRIs.
23. Distinctionmbetweenmimpulsivitymandmcompulsivitym-
mCORRECTmANSWERmImpulsivitymismriskymbehavior;mcompulsivitymismrepetitivemactsmtomreli
evemanxiety.
24. Cholinesteraseminhibitormthatmismalsomambutyrylcholinesteraseminhibitorm-
mCORRECTmANSWERmRivastigmine.
25. Medicationmmostmassociatedmwithmanticholinergicmsidemeffectsminmelderlym-
mCORRECTmANSWERmParoxetine.
26. Mainmclinicalmusemformmemantineminmdementiam-
mCORRECTmANSWERmModeratemtomseveremAlzheimer'smdisease.
27. EarliestmpresentingmsymptomminmAlzheimer'smdiseasem-mCORRECTmANSWERmShort-
termmmemorymloss.
28. Antidepressantmmostmlikelymtomcausemweightmgainm-mCORRECTmANSWERmMirtazapine.
29. PrimarymbenefitmofmusingmbupropionmasmadjunctmtomSSRIsm-
mCORRECTmANSWERmReducesmsexualmdysfunction.
30. Safestmantidepressantmformdepressionminmelderlym-mCORRECTmANSWERmEscitalopram.
31. Classmofmdrugsmcausingmhypertensivemcrisismwithmtyraminemfoodsm-
mCORRECTmANSWERmMAOIs.
CONCEPTS AND Q&A LATEST
2026/2027 ACTUAL EXAM QUESTIONS
WITH CORRECT ANSWERS 100%
VERIFIED GRADED A+
1. MechanismmofmSSRIsm-
mCORRECTmANSWERmInhibitmserotoninmreuptake,mincreasingmsynapticmserotonin.
2. SSRImwithmhighestmriskmofmdiscontinuationmsyndromem-mCORRECTmANSWERmParoxetine.
3. Neurotransmittersminmmonoaminemhypothesismofmdepressionm-
mCORRECTmANSWERmSerotonin,mnorepinephrine,mandmdopamine.
4. SafestmSSRIminmpolypharmacymandmelderlym-mCORRECTmANSWERmEscitalopram.
5. Classmofmantidepressantmrequiringmdietarymtyraminemrestrictionm-
mCORRECTmANSWERmMAOIs.
6. Hallmarkmsymptommofmserotoninmsyndromem-
mCORRECTmANSWERmHyperreflexiamandmclonus.
7. Opioidmwithdrawalmmedicationmwithmceilingmeffectm-mCORRECTmANSWERmBuprenorphine.
8. Medicationmcontraindicatedminmeatingmdisordersm-mCORRECTmANSWERmBupropion.
9. Antidepressantmassociatedmwithmpriapismm-mCORRECTmANSWERmTrazodone.
,10. MostmactivatingmSSRImthatmmaymworsenmanxietym-mCORRECTmANSWERmFluoxetine.
11. Medicationmclassmbestmavoidedminmelderlym-mCORRECTmANSWERmBenzodiazepines.
12. Mechanismmofmactionmofmmemantinem-mCORRECTmANSWERmNMDAmreceptormantagonist.
13. Dementiammedicationmderivedmfrommdaffodilsm-mCORRECTmANSWERmGalantamine.
14. Brainmregionmessentialmformmemorymformationm-mCORRECTmANSWERmHippocampus.
15. Uniquemriskmofmlamotriginemtherapym-mCORRECTmANSWERmStevens-Johnsonmsyndrome.
16. First-linemmedicationmformrestlessmlegsmsyndromem-mCORRECTmANSWERmRopinirole.
17. MOAmofmatomoxetinemformADHDm-
mCORRECTmANSWERmNorepinephrinemreuptakeminhibition.
18. PreferredmADHDmmedicationmformpatientsmwithmsubstancemusemhistorym-
mCORRECTmANSWERmAtomoxetine.
19. Majormsidemeffectmofmdonepezilm-mCORRECTmANSWERmGImdistressm(nausea,mdiarrhea).
20. BiomarkermelevatedminmAlzheimer'smdiseasemtanglesm-mCORRECTmANSWERmTaumprotein.
21. Keymcounselingmpointmformcholinesteraseminhibitorsm-
mCORRECTmANSWERmStartmlowmandmincreasemslowlymtomminimizemGImupset.
, 22. Preferredmfirst-linemtreatmentmformagitationminmdementiam-
mCORRECTmANSWERmSSRIs/SNRIs.
23. Distinctionmbetweenmimpulsivitymandmcompulsivitym-
mCORRECTmANSWERmImpulsivitymismriskymbehavior;mcompulsivitymismrepetitivemactsmtomreli
evemanxiety.
24. Cholinesteraseminhibitormthatmismalsomambutyrylcholinesteraseminhibitorm-
mCORRECTmANSWERmRivastigmine.
25. Medicationmmostmassociatedmwithmanticholinergicmsidemeffectsminmelderlym-
mCORRECTmANSWERmParoxetine.
26. Mainmclinicalmusemformmemantineminmdementiam-
mCORRECTmANSWERmModeratemtomseveremAlzheimer'smdisease.
27. EarliestmpresentingmsymptomminmAlzheimer'smdiseasem-mCORRECTmANSWERmShort-
termmmemorymloss.
28. Antidepressantmmostmlikelymtomcausemweightmgainm-mCORRECTmANSWERmMirtazapine.
29. PrimarymbenefitmofmusingmbupropionmasmadjunctmtomSSRIsm-
mCORRECTmANSWERmReducesmsexualmdysfunction.
30. Safestmantidepressantmformdepressionminmelderlym-mCORRECTmANSWERmEscitalopram.
31. Classmofmdrugsmcausingmhypertensivemcrisismwithmtyraminemfoodsm-
mCORRECTmANSWERmMAOIs.